Clinical utility of asthma biomarkers: from bench to bedside
Susanne JH Vijverberg,1,2,* Bart Hilvering,2,* Jan AM Raaijmakers,1 Jan-Willem J Lammers,2 Anke-Hilse Maitland-van der Zee,1,* Leo Koenderman2,* 1Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht...
Guardado en:
Autores principales: | Vijverberg SJH, Hilvering B, Raaijmakers JA, Lammers JW, Maitland-van der Zee AH, Koenderman L |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/348ae29b0f974485abe0fad6031c8748 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Oncolytic Virotherapy: From Bench to Bedside
por: Ludi Yang, et al.
Publicado: (2021) -
Inflammation, Bone Healing and Osteonecrosis: From Bedside to Bench
por: Goodman SB, et al.
Publicado: (2020) -
Antineutrophil cytoplasmic antibodies-associated glomerulonephritis: From bench to bedside
por: Yong-Xi Chen, et al.
Publicado: (2018) -
From bench to bedside: use of human adipose-derived stem cells
por: Feisst V, et al.
Publicado: (2015) -
Translation of a spinal bone cement product from bench to bedside
por: Fei Feng, et al.
Publicado: (2022)